Education/ACR/EULAR

Grappa Symposium: Leung Obesity in PsA - done deal @RheumNow #APLAR2026 https://t.co/3YQT4kiPer

An important and relevant reminder from @rheumarhyme on AI use @RheumNow #APLAR2026 https://t.co/7Ratb6aQOD

https://x.com/RHEUMarampa/status/2116369684358684894/photo/1

AI can be helpful in manuscript creation As the author: > always verify the draft - allow time to check > take full responsibility of the content - review and revise the final manuscript @RheumNow #APLAR2026 https://t.co/cQsEtDc7z1

The @RheumNow crew together at #APLAR2026 https://t.co/9YizHIFprF

https://x.com/JihaRheum/status/2116043911718441344/photo/1

Dr. Cush reviews the news and journal reports from this past week on RheumNow. This week on the podcast: hopeful guidelines for PMR; certainty about good & bad beverages in gout; mixed results in Sjogren's; non-lupus drugs saves lupus lives; and big hips sink ships in psoriatic https://t.co/TPqPKP5MRl

Advances and Challenges in Lupus Care: Insights from RheumNow Survey Findings Listen to leading rheumatology and dermatology experts for an engaging discussion on the evolving landscape of Cutaneous Lupus Erythematosus (CLE) and Systemic Lupus Erythematosus (SLE). https://t.co/lJOzeR81AS

ACR Convergence 2026 is almost here. Whether you’re attending in person or following from afar, RheumNow will bring you the research, clinical updates and expert insights you need to know. Join us for #ACR26 coverage beginning November 7th at https://t.co/ofGKCCNQnE. #ACR26 https://t.co/lMJSrkxMlN

Home | RheumNow

Article

Mixed Drinks, Mixed Results (10.30.2026)

Jack Cush, MD Oct 30, 2026

Dr. Cush reviews the news and journal reports from this past week on RheumNow. This week on the podcast: hopeful guidelines for PMR; certainty about good & bad beverages in gout; mixed results in Sjogren's; non-lupus drugs saves lupus lives; and big hips sink ships in psoriatic arthritis

Excites to report on #APLAR26 in Seoul, S. Korea for @RheumNow along with Drs. @RHEUMarampa and Peter Nash https://t.co/QImSxM7Izi

https://x.com/JihaRheum/status/2115969557945032869/photo/1

Saag GIOP guidelines APLAR Seoul 2026 #GIOP #RheumNow https://t.co/HIEHcaQDeO

https://x.com/drpnash/status/2116001702998642747/photo/1

Oswestry Disability Index in axSpA (n=107, India): a patient-reported, low-cost, quick tool that tracked closely with BASDAI (r=0.77), BASFI (r=0.80) and ASDAS-CRP (r=0.79). Could help where rheumatologists are scarce. P#478 #APLAR26 @RheumNow https://t.co/teoMtnM3Gl

https://x.com/JihaRheum/status/2115985118280224811/photo/1

evidence T2T in SLE is wortwhile APLAR Seoul 2026 Nikpour #SLE #RheumNow

A positive SI joint MRI alone is not specific for axSpA: ASAS MRI-positive in 23.4% of healthy volunteers, 12.5% of runners and 57.1% of postpartum back pain, vs 91.5% of axSpA. Without clinical context, overdiagnosis is a risk. AYR session #APLAR26 @RheumNow https://t.co/U3wFOm01B4

2026 BSR Guideline for the Treatment of Polymyalgia Rheumatica Toyoda and colleagues from the British Society for Rheumatology have published new PMR treatment guidelines to supercede the previously published 2009 BSR/BHPR PMR guidelines. https://t.co/o1Y1a13WIG https://t.co/W9jNGfMgP7

2026 BSR Guideline for the Treatment of Polymyalgia Rheumatica | RheumNow

2024 web survey of German rheumatologists on CAR-T & T-cell redirecting therapies. 95% willing to refer pts to specialized centers; but 5% (most severe) are suitable for TCRT. Barriers cited: high costs (82%), limited experience (65%) & limited # appropriate Pts (35%). 4.86/10 https://t.co/o62uRVsIC7

Mark your calendar: RheumNow is covering ACR Convergence 2026, beginning November 7th! Follow along for clinical trial highlights, expert perspectives, daily faculty recaps, livestreams and more. Visit https://t.co/ofGKCCNQnE for the latest coverage. #ACR26 #Rheumatology https://t.co/5p5UxMLu51

Home | RheumNow

Article

2026 BSR Guideline for the Treatment of Polymyalgia Rheumatica

Jack Cush, MD Oct 27, 2026

Toyoda and colleagues from the British Society for Rheumatology have published new PMR treatment guidelines to supercede the previously published 2009 BSR/BHPR PMR guidelines. These guidelines emphasize earlier specialist input, methotrexate as an option, and bone protection for all PMR patients

Comorbidity management is subpar in Rheum. Surveys of 2213 inflamm rheum Dz pts & 140 rheumatologists. Rheums think theyre OK (71-92%) screening (HTN, OP, vaccines, CA), but pts say NOT (12=33%).Rheums agree they have no structured comorbidity screening in place (time 91%, https://t.co/mqcptziRdw

Article

Double Trouble (10.23.2026)

Jack Cush, MD Oct 23, 2026

Dr. Jack Cush reviews the journal articles and regulatory announcements from this past week on RheumNow, including: two crystals in one joint, twice the cryptococcus risk in JAKs; Myositis and Scleroderma; and Sjögren’s plus early damage = >> 2 fold risk lymphoma. Double trouble week

RheumNow Live 2027 registration is NOW OPEN. GLP-1s in your clinic. CAR-T in lupus. Rheumatology experts vs. AI, with your vote. Jan. 30–31 | Onsite + virtual Early Bird Pricing through 12/15/2026. See the agenda. Register: https://t.co/zYYC2350tE https://t.co/QeSxDPlIpv

RheumNow

RheumNow Live 2027 registration is NOW OPEN. GLP-1s in your clinic. CAR-T in lupus. Rheumatology experts vs. AI, with your vote. Jan. 30–31 | Onsite + virtual Early Bird Pricing through 12/15/2026. See the agenda. Register: https://t.co/zYYC2350tE https://t.co/mPdcOhbrC6

RheumNow

Open Evidence study of 952 008 US clinicians (556K MDs), submitted 271 million AI clinical queries over 2.5 yrs study period. MDs submitted ~371 queries/mo - 33% for Rx & 14% fo Dx. Highest use w/ young MD, oncology, hematology, Int medicine, & family medicine https://t.co/FGErefxWD5

Congratulations to John J. Cush, MD, of @RheumNow, recipient of the ACR Distinguished Clinician Scholar Award. The award recognizes his outstanding contributions to clinical medicine, scholarship, and education in rheumatology. #ACR26 https://t.co/9wWLjQNnxH

https://x.com/ACRheum/status/2110881413402689797/photo/1

Lancet: A Public Health Policy Call Out for Osteoarthritis In honor of World Arthritis Day (Oct. 12th), The Lancet has published a public Health Policy report is to "outline a globally relevant roadmap to address the osteoarthritis identity problem, focusing on health policy https://t.co/XTRDJnOEGn

Kenneth G. Saag, M.D., https://t.co/TJOX58X5d5., Named North American Editor-in-Chief of Osteoporosis International; Dr. Saag also will oversee Archives of Osteoporosis in collaboration with the International Osteoporosis Foundation (IOF). Ken is a professor of medicine and https://t.co/KouJoStW5C